News | RIVM

Use of e-health increases but not always effective

2021 saw an increase in the use of e-health in every part of the healthcare industry in comparison with 2019. There were several reasons for this, including the coronavirus pandemic.

Nurse uses digital device for registering patient data at elderly home

The National Immunisation Programme: the number of disease notifications decreased substantially in 2020

In 2020, fewer people fell ill from a disease against which vaccination is included in the National Immunisation Programme than in 2019. This is most likely due to coronavirus measures, such as social distancing, handwashing, and travel restrictions.

Vaccination coverage increases for second consecutive year, by 10% for HPV

The percentage of children receiving vaccinations from the National Immunisation Programme rose again last year. Another striking note is the 10% increase in HPV vaccination, rising to 63%.

Het aantal jonge vrouwen dat zich laat vaccineren tegen HPV is toegenomen met 10%

Method for safe and sustainable recycling of waste

The method developed by RIVM to assess whether waste treatment is sufficiently safe and sustainable, can contribute to the European ambitions for a safe and more circular economy.

Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years

National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.

Corona crisis has limited impact on infant participation in National Immunisation Programme

Nearly all infants in the Netherlands are still participating in the National Immunisation Programme.

More children vaccinated against mumps, measles, rubella and HPV

The percentage of newborns participating in the immunisation programme targeting mumps, measles and rubella rose slightly over the past year.

A pregnant woman can protect her baby against whooping cough with 22-week vaccination

From 16 December 2019, pregnant women in the Netherlands will be offered the 22-week vaccination. With this vaccination, a pregnant woman protects her child and herself against whooping cough.

Report on the developments of the National Immunisation Programme: stabilisation of participation and low level of disease

In the first six months of 2019, the number of notified meningococcal serogroup W (MenW) disease cases decreased in almost all age groups, after a continuous increase since 2015.

State Secretary Blokhuis: boys will also be vaccinated against HPV virus

The vaccine against the HPV human papillomavirus virus will also become available for boys.